{"id":539771,"date":"2021-04-21T19:28:01","date_gmt":"2021-04-21T19:28:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=539771"},"modified":"2021-04-21T19:28:01","modified_gmt":"2021-04-21T19:28:01","slug":"small-fiber-neuropathy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-vertex-pharmaceuticals-biogen-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/small-fiber-neuropathy-pipeline-emerging-therapies-and-key-pharma-players-involved-by-delveinsight-vertex-pharmaceuticals-biogen-and-others_539771.html","title":{"rendered":"Small Fiber Neuropathy Pipeline: Emerging Therapies and Key pharma players involved by DelveInsight | Vertex Pharmaceuticals, Biogen and Others."},"content":{"rendered":"
\"Small<\/a><\/p>\n
\n
Small Fiber Neuropathy Pipeline<\/div>\n<\/div>\n<\/div>\n

Small fiber neuropathy<\/strong> occurs as a result of damage to the small fibers of the peripheral nervous system are damaged. Small fibers in the skin carries sensory information about pain and temperature. In the organs, these small fibers regulate automatic functions such as heart rate and breathing. Small fiber neuropathy may sometimes be a sign of an underlying health condition, such as diabetes or an autoimmune disease. Most small fiber neuropathies occur in a length-dependent fashion, resulting in loss of function in a stocking distribution in the lower extremities. When the condition is more advanced, a glove-like loss in the upper extremities also may occur. In rare cases, a non–length dependent neuropathy results in symptoms involving the trunk, face, proximal limbs, or other focal areas. Pain in the feet and hands is the most common early symptom of small fiber neuropathy.<\/p>\n

DelveInsight’s, “Small Fiber Neuropathy Pipeline<\/a> Insight, 2021,”<\/strong> report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Small Fiber Neuropathy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.<\/p>\n

 <\/p>\n

Request for Free Sample Report: https:\/\/www.delveinsight.com\/sample-request\/small-fiber-neuropathy-pipeline-insight<\/a><\/strong><\/p>\n

 <\/p>\n

Some of Small Fiber Neuropathy Companies are:<\/strong><\/p>\n